Home » Market News » DirectorsTalk Highlights » Avacta listed in Business Weekly’s “The Killer 50: Ones2Watch”
Avacta Group Plc

Avacta listed in Business Weekly’s “The Killer 50: Ones2Watch”

Avacta has been listed in Business Weekly’s “The Killer 50: Ones2Watch”

Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.